Stefano Maria Massimiliano. Basso
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Stefano Maria Massimiliano. Basso has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Franco Lumachi
School of Medicine, University of Padua
74 shared publications Giordano B Chiara
14 shared publications- Davide Adriano Santeufemia
Clinical Oncology, S. Maria degli Angeli Hospital, Pordenone, Italy
13 shared publications Mario Ermani
Department of Neurosciences, Statistic and Informatics Unit, University of Padua, School of Medicine, Padua, Italy
11 shared publications- Giovanni Lo Re
Medical Oncology Department, Santa Maria degli Angeli Hospital, Pordenone, Italy
9 shared publications - Alba Ariela Brandes
Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
7 shared publications
Latest Publications
- Open Access
- 24 May 2022
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (7) , e1003-e1011
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
- 24 May 2022
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (7) , e1003-e1011
Open AccessEffects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
- 1 October 2020
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 40 (10) , 5877-5881
Diagnostic Accuracy of Pleural Fluid Cytology, Carcinoembryonic Antigen and C-Reactive Protein Together in Patients With Pulmonary Metastases and Malignant Pleural Effusion
Background/Aim: Pleural effusion (PE) has a heterogeneous aetiology, and differential diagnosis between benign and malignant disease may require invasive procedures in up to 60% of cases. The sensitivity of pleural cytology is limited, and several strategies have been tested to reduce the need of invasive diagnostic approaches. The aim of this study was to evaluate the usefulness of pleural fluid cytology, compared to, and combined with, carcinoembryonic antigen (CEA), C reactive protein (CRP), and lactate dehydrogenase (LDH) assay of pleural fluid (PF) in patients with a history of cancer, exudative non-purulent PE, and suspicion of malignant PE on imaging studies. Patients and Methods: The medical records of 40 patients with pulmonary metastases and malignant PE, and 57 controls with benign exudative PE were reviewed. All the patients underwent pleural cytology and CEA, CRP, and LDH assay before VATS-guided biopsy. Results: The sensitivity and specificity were 55.0% and 98.2% (cytology), 35.0% and 98.2% (CEA), 92.5% and 71.9% (CRP), 70.0% and 54.4% (LDH). The multivariate analysis excluded LDH, and the final AUC (cytology+CEA+CRP) was 0.894. Conclusion: In all patients with a history of cancer and PE of uncertain origin, the combination of PF cytology plus pleural CEA and CRP assay together should be suggested to recognize malignant plural effusion (MPE), minimising the use of unnecessary invasive investigations.
- 1 October 2020
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 40 (10) , 5877-5881
Diagnostic Accuracy of Pleural Fluid Cytology, Carcinoembryonic Antigen and C-Reactive Protein Together in Patients With Pulmonary Metastases and Malignant Pleural Effusion
Background/Aim: Pleural effusion (PE) has a heterogeneous aetiology, and differential diagnosis between benign and malignant disease may require invasive procedures in up to 60% of cases. The sensitivity of pleural cytology is limited, and several strategies have been tested to reduce the need of invasive diagnostic approaches. The aim of this study was to evaluate the usefulness of pleural fluid cytology, compared to, and combined with, carcinoembryonic antigen (CEA), C reactive protein (CRP), and lactate dehydrogenase (LDH) assay of pleural fluid (PF) in patients with a history of cancer, exudative non-purulent PE, and suspicion of malignant PE on imaging studies. Patients and Methods: The medical records of 40 patients with pulmonary metastases and malignant PE, and 57 controls with benign exudative PE were reviewed. All the patients underwent pleural cytology and CEA, CRP, and LDH assay before VATS-guided biopsy. Results: The sensitivity and specificity were 55.0% and 98.2% (cytology), 35.0% and 98.2% (CEA), 92.5% and 71.9% (CRP), 70.0% and 54.4% (LDH). The multivariate analysis excluded LDH, and the final AUC (cytology+CEA+CRP) was 0.894. Conclusion: In all patients with a history of cancer and PE of uncertain origin, the combination of PF cytology plus pleural CEA and CRP assay together should be suggested to recognize malignant plural effusion (MPE), minimising the use of unnecessary invasive investigations.
- Open Access
- 2 May 2018
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 38 (5) , 3049-3054
Bone Mineral Density as a Potential Predictive Factor for Luminal-type Breast Cancer in Postmenopausal Women
Background/Aim: We performed a case-control study to evaluate whether bone mineral density (BMD) can be considered a potential predictive factor for luminal-type breast cancer (BC), that could be useful in constructing a predictive risk model. Materials and Methods: The medical records of 297 postmenopausal women with luminal-type node-negative BC who underwent lumbar-spine dual-energy X-ray absorptiometry (DXA) with BMD measurement before surgery, were analyzed and compared with those of 297 age-matched randomly selected healthy controls. The correlations between women's reproductive history, including the age at menarche and menopause, parity, oral contraceptives and hormone replacement therapy (HRT) use, the results of DXA, and BC risk were evaluated in univariate and multivariate analyses. Results: Overall, 168 (28.3%) women had osteoporosis and/or osteopenia (low BMD). Both bone alterations were protective factors for BC, especially when they were considered together (p=0.001). Only the interval between menarche and menopause (MMI), dichotomized at 37.5 years as an optimal cut-off, and the HRT use reached a statistical significance (p<0.01) as risk factors. The three parameters were independent because they remained significant in the stepwise logistic regression analysis. The area under the receiver operating characteristic (ROC) curve (AUC) obtained with the model was 0.694 (95%CI=0.694-0.731). Conclusion: This hypothesized predictive model is fairly accurate and could identify patients at increased risk of developing luminal-type BC in a population of postmenopausal women who performed DXA, simply based on their history.
- 2 May 2018
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 38 (5) , 3049-3054
Open AccessBone Mineral Density as a Potential Predictive Factor for Luminal-type Breast Cancer in Postmenopausal Women
Background/Aim: We performed a case-control study to evaluate whether bone mineral density (BMD) can be considered a potential predictive factor for luminal-type breast cancer (BC), that could be useful in constructing a predictive risk model. Materials and Methods: The medical records of 297 postmenopausal women with luminal-type node-negative BC who underwent lumbar-spine dual-energy X-ray absorptiometry (DXA) with BMD measurement before surgery, were analyzed and compared with those of 297 age-matched randomly selected healthy controls. The correlations between women's reproductive history, including the age at menarche and menopause, parity, oral contraceptives and hormone replacement therapy (HRT) use, the results of DXA, and BC risk were evaluated in univariate and multivariate analyses. Results: Overall, 168 (28.3%) women had osteoporosis and/or osteopenia (low BMD). Both bone alterations were protective factors for BC, especially when they were considered together (p=0.001). Only the interval between menarche and menopause (MMI), dichotomized at 37.5 years as an optimal cut-off, and the HRT use reached a statistical significance (p<0.01) as risk factors. The three parameters were independent because they remained significant in the stepwise logistic regression analysis. The area under the receiver operating characteristic (ROC) curve (AUC) obtained with the model was 0.694 (95%CI=0.694-0.731). Conclusion: This hypothesized predictive model is fairly accurate and could identify patients at increased risk of developing luminal-type BC in a population of postmenopausal women who performed DXA, simply based on their history.
- Top Cited PapersOpen Access
- 1 May 2018
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 18 (5) , 516-525
Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study
- 1 May 2018
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 18 (5) , 516-525
Top Cited PapersOpen AccessSurgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study
- 1 January 2018
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 10 (1) , 121-125
Editorial on “Growth patterns of pulmonary metastases: should we adjust resection techniques to primary histology and size?”
Editorial on “Growth patterns of pulmonary metastases: should we adjust resection techniques to primary histology and size?”
- 1 January 2018
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 10 (1) , 121-125
Editorial on “Growth patterns of pulmonary metastases: should we adjust resection techniques to primary histology and size?”
Editorial on “Growth patterns of pulmonary metastases: should we adjust resection techniques to primary histology and size?”
- Open Access
- 30 June 2017
- Published by OAE Publishing Inc. in Mini-invasive Surgery
Mini-invasive distal pancreatectomy: a feasible and cost-effective technique
Mini-Invasive Surgery is a journal covers endoscopy and other minimally invasive procedures including urology, orthopedics, neurosurgery, otolaryngology, gynecology and general surgery.
- 30 June 2017
- Published by OAE Publishing Inc. in Mini-invasive Surgery
Open AccessMini-invasive distal pancreatectomy: a feasible and cost-effective technique
Mini-Invasive Surgery is a journal covers endoscopy and other minimally invasive procedures including urology, orthopedics, neurosurgery, otolaryngology, gynecology and general surgery.
- Open Access
- 1 April 2017
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 37 (4) , 1971-1974
Analysis of Factors Affecting Short-term Results in Elderly Patients Undergoing Elective Surgical Resection for Stage I-II Colon Cancer
Aim: The aim of this study was to analyze the influence of comorbidities and to compare the short-term results of elective surgical resection of stage I-II colon adenocarcinoma in elderly (≥65 years) versus younger patients. Patients and Methods: Two groups of sex-matched younger and older patients were compared: Group A: N=36, median age 58 (range=43-65) years; and group B: N=67, median age 73 (range=66-86) years. Results: Overall, 71 out of 103 (68.9%) patients had one or more comorbidities. A greater number of older patients had an American Society of Anesthesiologists (ASA) score >2 (p=0.004) and were on multiple medications (polypharmacy) (p=0.016), but the distribution of the other parameters was similar (p≥0.05). Intra- and postoperative complications in group A vs. B occurred in 25.0% vs. 26.9%, and 47.2% vs. 64.2%, respectively (p≥0.05). Conclusion: Elderly patients with colon cancer scheduled to elective surgical resection should not be considered at increased risk of intra- or short-term postoperative complications with respect to younger patients. However, they require careful individual preoperative evaluation because they are usually polypharmacy users and have a higher ASA score.
- 1 April 2017
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 37 (4) , 1971-1974
Open AccessAnalysis of Factors Affecting Short-term Results in Elderly Patients Undergoing Elective Surgical Resection for Stage I-II Colon Cancer
Aim: The aim of this study was to analyze the influence of comorbidities and to compare the short-term results of elective surgical resection of stage I-II colon adenocarcinoma in elderly (≥65 years) versus younger patients. Patients and Methods: Two groups of sex-matched younger and older patients were compared: Group A: N=36, median age 58 (range=43-65) years; and group B: N=67, median age 73 (range=66-86) years. Results: Overall, 71 out of 103 (68.9%) patients had one or more comorbidities. A greater number of older patients had an American Society of Anesthesiologists (ASA) score >2 (p=0.004) and were on multiple medications (polypharmacy) (p=0.016), but the distribution of the other parameters was similar (p≥0.05). Intra- and postoperative complications in group A vs. B occurred in 25.0% vs. 26.9%, and 47.2% vs. 64.2%, respectively (p≥0.05). Conclusion: Elderly patients with colon cancer scheduled to elective surgical resection should not be considered at increased risk of intra- or short-term postoperative complications with respect to younger patients. However, they require careful individual preoperative evaluation because they are usually polypharmacy users and have a higher ASA score.
- 18 January 2017
- Published by Wiley in Clinical Otolaryngology
- Vol. 42 (3) , 668-672
Image‐guided fine‐needle aspiration cytology and flow cytometry phenotyping of neck lymphadenopathy for the diagnosis of recurrent lymphoma
In patients with a history of lymphoma, each lymphadenopathy should be carefully evaluated. The aims of this study were to evaluate (i) the usefulness of high-resolution ultrasonography (US), US-guided fine-needle aspiration cytology (FNAC) and flow cytometry phenotyping (FCP) together in the diagnosis of recurrent lymphoma and (ii) whether these tools were independent predictors of correct results. Retrospective cohort study with stepwise forward logistic regression analysis of results. Tertiary referral centre. A total of 151 patients with a history of lymphoma who developed a cervical mass during follow-up. On neck US, a lymphadenopathy was shown in 129 (85.4%) patients (median age 57 years, range 18–78 years), and US-guided FNAC combined with FCP were immediately performed. All patients had surgical excision and subsequent histological examination of the enlarged node(s), to establish lymphoma subclassification. Final histology confirmed recurrence in 82 (63.6%) patients. According to the logistic regression analysis, FNAC and FCP were independent predictors of correct results (P = 0.009 and 0.028, respectively) and did not interfere with each other. The sensitivity, specificity and accuracy of the combination of all of the tools were 98.8%, 100% and 99.2%, respectively, and the area under the receiver operating characteristic curve was 0.902 (95% CI: 0.797–0.986). This minimally invasive procedure is easily performed and should be recommended for all patients with cervical lymphadenopathy and a history of lymphoma, avoiding the need of core-biopsy or surgical excision if recurrence was excluded.
- 18 January 2017
- Published by Wiley in Clinical Otolaryngology
- Vol. 42 (3) , 668-672
Image‐guided fine‐needle aspiration cytology and flow cytometry phenotyping of neck lymphadenopathy for the diagnosis of recurrent lymphoma
In patients with a history of lymphoma, each lymphadenopathy should be carefully evaluated. The aims of this study were to evaluate (i) the usefulness of high-resolution ultrasonography (US), US-guided fine-needle aspiration cytology (FNAC) and flow cytometry phenotyping (FCP) together in the diagnosis of recurrent lymphoma and (ii) whether these tools were independent predictors of correct results. Retrospective cohort study with stepwise forward logistic regression analysis of results. Tertiary referral centre. A total of 151 patients with a history of lymphoma who developed a cervical mass during follow-up. On neck US, a lymphadenopathy was shown in 129 (85.4%) patients (median age 57 years, range 18–78 years), and US-guided FNAC combined with FCP were immediately performed. All patients had surgical excision and subsequent histological examination of the enlarged node(s), to establish lymphoma subclassification. Final histology confirmed recurrence in 82 (63.6%) patients. According to the logistic regression analysis, FNAC and FCP were independent predictors of correct results (P = 0.009 and 0.028, respectively) and did not interfere with each other. The sensitivity, specificity and accuracy of the combination of all of the tools were 98.8%, 100% and 99.2%, respectively, and the area under the receiver operating characteristic curve was 0.902 (95% CI: 0.797–0.986). This minimally invasive procedure is easily performed and should be recommended for all patients with cervical lymphadenopathy and a history of lymphoma, avoiding the need of core-biopsy or surgical excision if recurrence was excluded.
- 1 November 2016
- Published by Elsevier in Clinical Biochemistry
- Vol. 49 (16-17) , 1227-1231
Evaluation of predictive value of pleural CEA in patients with pleural effusions and histological findings: A prospective study and literature review
- 1 November 2016
- Published by Elsevier in Clinical Biochemistry
- Vol. 49 (16-17) , 1227-1231
Evaluation of predictive value of pleural CEA in patients with pleural effusions and histological findings: A prospective study and literature review
- 1 September 2016
- Published by Elsevier in Clinica Chimica Acta
- Vol. 460, 227-230
Bone turnover markers in women with early stage breast cancer who developed bone metastases. A prospective study with multivariate logistic regression analysis of accuracy
- 1 September 2016
- Published by Elsevier in Clinica Chimica Acta
- Vol. 460, 227-230
Bone turnover markers in women with early stage breast cancer who developed bone metastases. A prospective study with multivariate logistic regression analysis of accuracy